“Comparative Study Between Combination Therapy Empagliflozin–Sitagliptin and Empagliflozin–Alogliptin in Addition to Metformin Assessing the Hypoglycemic Effect on Patients Diagnosed With Malignancy and Poorly Controlled Type 2 Diabetes Mellitus As Comorbidity”. Journal of Carcinogenesis, vol. 24, no. 3, Sept. 2025, pp. 669-74, https://doi.org/10.64149/J.Carcinog.24.3.669-674.